Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tong Ren Tang Technologies Co ( (HK:1666) ) just unveiled an update.
Tong Ren Tang Technologies Co. Ltd. has announced the current composition of its board of directors, led by Chairman Zhang Yi and General Manager Zhang Chun You, and comprising executive, non-executive, independent non-executive and an employee director. The company has also confirmed the membership and chairpersons of its four key board committees—Audit, Nomination, Remuneration, and Strategy and Planning—clarifying governance responsibilities and reinforcing its corporate oversight framework, a move likely aimed at enhancing transparency and strategic decision-making for investors and other stakeholders.
The most recent analyst rating on (HK:1666) stock is a Hold with a HK$4.50 price target. To see the full list of analyst forecasts on Tong Ren Tang Technologies Co stock, see the HK:1666 Stock Forecast page.
More about Tong Ren Tang Technologies Co
Tong Ren Tang Technologies Co. Ltd. is a joint stock company incorporated in the People’s Republic of China with limited liability and is listed on the Hong Kong Stock Exchange under stock code 1666. The company operates in the pharmaceutical and traditional Chinese medicine sector, focusing on the production and sale of herbal and related healthcare products in domestic and international markets.
Average Trading Volume: 1,091,243
Technical Sentiment Signal: Sell
Current Market Cap: HK$5.46B
See more data about 1666 stock on TipRanks’ Stock Analysis page.

